Steven Richard Hirsch

Steven Richard Hirsch's AcademicInfluence.com Rankings

Biology

#16182

Historical Rank

Neuroscience

#2207

Historical Rank

biology Degrees

Download Badge

Biology

Steven Richard Hirsch's Degrees

Doctorate Psychiatry Stanford University

Why Is Steven Richard Hirsch Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Steven Richard Hirsch's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Patterns of Cerebral Blood Flow in Schizophrenia (1992) (906)
Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia (1998) (708)
Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group. (1997) (508)
A PET study of voluntary movement in schizophrenic patients experiencing passivity phenomena (delusions of alien control). (1997) (453)
Mismatch negativity potentials and cognitive impairment in schizophrenia (2004) (279)
The left medial temporal region and schizophrenia. A PET study. (1992) (275)
Outpatient Maintenance of Chronic Schizophrenic Patients with Long-acting Fluphenazine: Double-blind Placebo (1973) (227)
"Revealed" Depression and drug treatment for schizophrenia. (1981) (226)
15O POSITRON EMISSION TOMOGRAPHIC SCANNING IN PREDOMINANTLY NEVER-TREATED ACUTE SCHIZOPHRENIC PATIENTS (1983) (205)
Functional anatomy of verbal fluency in people with schizophrenia and those at genetic risk (2000) (201)
Pragmatic evaluation of computer-aided self-help for anxiety and depression (2003) (188)
Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function (2009) (179)
Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical and social outcome at two years. (1990) (173)
γ-band electroencephalographic oscillations in a patient with somatic hallucinations (1998) (169)
Depression in schizophrenia: recognition and management in the USA (2001) (130)
Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical outcome at one year. (1989) (125)
Predicting psychiatric admission rates. (1992) (124)
Impairment in frontal but not temporal components of mismatch negativity in schizophrenia. (2002) (119)
Prefrontal cortex activity in people with schizophrenia and control subjects (1998) (116)
A Pivotal Role for Glutamate in the Pathogenesis of Schizophrenia, and Its Cognitive Dysfunction (1997) (115)
Life Events and Maintenance Therapy in Schizophrenic Relapse (1973) (110)
NMDA receptor mRNA correlation with antemortem cognitive impairment in schizophrenia. (1996) (105)
Astrocyte decrease in the subgenual cingulate and callosal genu in schizophrenia (2013) (104)
The Dysphoric Syndrome in Schizophrenia and its Implications for Relapse (1989) (102)
Eeg Spectral Analysis in Schizophrenia (1980) (101)
The Social Behaviour Assessment Schedule (SBAS): Rationale, contents, scoring and reliability of a new interview schedule (1980) (100)
Shortening hospital stay for psychiatric care: effect on patients and their families (1979) (98)
Elevated platelet calcium mobilization and nitric oxide synthase activity may reflect abnormalities in schizophrenic brain. (1995) (96)
A One Year Prospective Study of the Effect of Life Events and Medication in the Aetiology of Schizophrenic Relapse (1996) (92)
A 28-week comparison of ziprasidone and haloperidol in outpatients with stable schizophrenia (1999) (90)
Psychiatric symptoms in self-poisoning patients (1979) (89)
Elevated endogenous nitric oxide synthase inhibitor in schizophrenic plasma may reflect abnormalities in brain nitric oxide production (1996) (86)
I. Course of Illness, Stability of Diagnosis, and the Role of a Special Maintenance Clinic (1985) (82)
Dysphoric and depressive symptoms in chronic schizophrenia (1989) (82)
Depression ‘Revealed’ in Schizophrenia (1982) (82)
Evaluating a community psychiatric service: Edited by J.K. Wing and Anthea M. Hailey. Oxford University Press, London, 1972. pp. 446. Price £6.50 (1973) (81)
Mismatch negativity indexes illness-specific impairments of cortical plasticity in schizophrenia: a comparison with bipolar disorder and Alzheimer's disease. (2015) (80)
Severe lithium toxicity with "normal" serum concentrations. (1978) (77)
Psychiatric beds and resources : factors influencing bed use and service planning (1988) (75)
Transcription and pathway analysis of the superior temporal cortex and anterior prefrontal cortex in schizophrenia (2011) (74)
Prophylactic lithium in affective disorders. (1971) (71)
A 28-week comparison of ziprasidone and haloperidol in outpatients with stable schizophrenia. (2002) (69)
Depressive and Extrapyramidal Symptoms and Clinical Effects: A Trial of Fluphenazine versus Flupenthixol in Maintenance of Schizophrenic Out-patients (1979) (68)
The Camden Schizophrenia Surveys (1996) (62)
Effect of propranolol and phenothiazines on electrodermal orienting and habituation in schizophrenia (1981) (59)
A volumetric biochemical niacin flush-based index that noninvasively detects fatty acid deficiency in schizophrenia (2002) (57)
III. Relapse Postponement or Relapse Prevention? The Implications for Long-term Outcome (1985) (54)
Clinical issues related to depression in schizophrenia: an international survey of psychiatrists (2002) (54)
DL‐propranolol and chlorpromazine following admission for schizophrenia (1981) (49)
A Comparison of Social Workers and Psychiatrists in Evaluating Parasuicide (1979) (49)
The Safety and Efficacy of Clozapine in Severe Treatment-Resistant Schizophrenic Patients in the UK (1993) (49)
Cholecystokinin messenger RNA deficit in frontal and temporal cerebral cortex in schizophrenia (1995) (48)
Clinical use of High-Dose Neuroleptics (1994) (48)
Parental abnormalities of verbal communication in the transmission of schizophrenia (1971) (46)
The Causality of Depression in Schizophrenia (1983) (45)
Down‐regulation of Dickkopf 3, a regulator of the Wnt signalling pathway, in elderly schizophrenic subjects (2005) (44)
The Suicide syndrome (1980) (44)
The platelet polyphosphoinositide system in Schizophrenia: The effects of neuroleptic treatment (1990) (44)
Does short term placebo treatment of chronic schizophrenia produce long term harm? (1986) (42)
ICI 204, 636: A New Atypical Antipsychotic Drug (1996) (42)
Orienting, habituation, sensitisation, and dishabituation in the electrodermal system of consecutive, drug free, admissions for schizophrenia (1981) (41)
Neuropathological changes in the substantia nigra in schizophrenia but not depression (2014) (41)
Cytomegalovirus and Schizophrenia (1985) (40)
Visual Evoked Potentials in Schizophrenia (1983) (40)
CONTROLLED CLINICAL TRIALS AND MEDICAL ETHICS (1979) (39)
Pathway and hemispheric differences in the event-related potential (ERP) to monaural stimulation: A comparison of schizophrenic patients with normal controls (1985) (39)
II. the Incidence of Compliance Problems, Side-effects, Neurotic Symptoms and Depression (1985) (38)
Clozapine: progress in treating refractory schizophrenia. (1993) (38)
(Des-Tyr1)-γ-endorphin in the treatment of schizophrenia (1981) (36)
PRECIPITATION OF ANTIPSYCHOTIC DRUGS IN INTERACTION WITH COFFEE OR TEA (1979) (36)
Fibrillary astrocytes are decreased in the subgenual cingulate in schizophrenia (2014) (35)
Investigation of G72 (DAOA) expression in the human brain (2008) (34)
Influenza Infection Causing Manic Psychosis (1972) (32)
Changes in cortical thickness in the frontal lobes in schizophrenia are a result of thinning of pyramidal cell layers (2011) (31)
Neuropathological changes in the nucleus basalis in schizophrenia (2013) (31)
Role of polyamines in the membrane pathology of schizophrenia a study using fibroblasts from schizophrenic patients and normal controls (1994) (30)
The Psychopharmacology and treatment of schizophrenia (1986) (30)
Nitric oxide, free radicals and polyamines may have a role in the membrane pathology of schizophrenia (1996) (30)
Themes and variations in European psychiatry. An anthology (1978) (30)
The causality of depression in schizophrenia. (1983) (29)
Abnormalities in parents of schizophrenics: A review of the literature and an investigation of communication defects and deviances (1975) (29)
Clinical Change as a Function of Brief Admission to Hospital in a Controlled Study Using the Present State Examination (1980) (28)
Schizophrenia, neurodevelopment, and disease. The Fifth Biannual Winter Workshop on Schizophrenia, Badgastein, Austria, January 28 to February 3, 1990. (1991) (28)
Effects of brief hospitalization on psychiatric patients' behaviour and social functioning (1981) (28)
Increased CSF amino acids and ventricular enlargement in schizophrenia: A preliminary study (1987) (28)
Does Propranolol have an Antipsychotic Effect? (1986) (26)
Inositol phospholipid turnover in platelets of schizophrenic patients. (1992) (25)
Raised cerebrospinal fluid phenylacetic acid concentration: preliminary support for the phenylethylamine hypothesis of schizophrenia? (1978) (25)
Decreased numerical density of kainate receptor-positive neurons in the orbitofrontal cortex of chronic schizophrenics (2006) (25)
Recruitment rates and factors affecting recruitment for a clinical trial of a putative anti‐psychotic agent in the treatment of acute schizophrenia (1992) (25)
Cholecystokinin CCK(B) receptor mRNA isoforms: expression in schizophrenic brains. (1999) (24)
Axonal myelin decrease in the splenium in major depressive disorder (2018) (24)
Cerebral asymmetries and stimulus intensity relationships in EEG spectra of VEPs in unmedicated schizophrenic patients: relationships with Active and Withdrawn syndromes. (1993) (23)
The third biannual winter workshop on schizophrenia. Schladming, Austria, Jan 26-31, 1986. (1986) (22)
Symptom dimensions in old-age schizophrenics Relationship to neuropsychological and motor abnormalities (1999) (22)
The effects of brief hospitalization upon the psychiatric patient's household (1981) (22)
Comparison between the Brief Psychiatric Rating Scale and the Manchester Scale for the rating of schizophrenic symptoms (1986) (21)
Electroconvulsive therapy for patient with cardiac pacemaker. (1979) (19)
Regional cerebral metabolic activity in chronic schizophrenia (1990) (19)
Caution and conservatism in the use of a psychiatric day hospital: Evidence from a research project that failed (1980) (19)
Depressive Disorder Due to Craniopharyngioma (1995) (18)
Intellectual Differences Between Schizophrenic Patients and Normal Controls Across the Adult Lifespan (2003) (17)
Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex (1996) (16)
Schizophrenia and Spectral Analysis of the Visual Evoked Potential (1984) (16)
Phenylacetic acid in CSF and serum in Indian schizophrenic patients (1991) (16)
Axonal myelin increase in the callosal genu in depression but not schizophrenia (2015) (15)
Chromosome anomalies, mental deficiency, and schizoprenia. A study of triple X and triple X/Y chromosomes in 5 patients and their families. (1963) (15)
Pitfalls and Problems of the Long Term Use of Neuroleptic Drugs in Schizophrenia (1993) (14)
Inadequate treatment response to des‐enkephalin‐gamma‐endorphin compared with thioridazine and placebo in schizophrenia (1992) (13)
Influence of D‐ or DL‐propranolol and chlorpromazine on habituation of phasic electrodermal responses in schizophrenia (1979) (13)
Bed Requirements for Acute Psychiatric Units--The Concept of a Norm (1983) (12)
Inhibitory action of spermidine on formyl-methionyl-leucyl-phenylalanine stimulated inositol phosphate production in human neutrophils. (1987) (12)
Oligodendrocyte density is changed in the basolateral amygdala in schizophrenia but not depression (2013) (12)
Dextro-propranolol in schizophrenia. (1980) (12)
Low dose maintenance medication for schizophrenia. (1986) (12)
Psychosocial factors in the cause and prevention of relapse in schizophrenia. (1983) (11)
Treatment of schizophrenic disorders: Algorithms for acute pharmacotherapy. (1997) (11)
Guidelines for biological Treatment of Schizophrenia, : Part 1: Acute Treatment of Schizophrenia and Part 2: Long-term Treatment of Schizophrenia (2005) (11)
Blood polyamine in schizophrenia (1989) (10)
Planning for Bed Needs and Resource Requirements in Acute Psychiatry (1987) (10)
Do parents cause schizophrenia? (1979) (10)
Criteria for Evaluating Improvement in Schizophrenia in Psychopharmacological Research (With Special Reference to Gamma Endorphin Fragments) (1988) (9)
A multicentre, double-blind, placebo-controlled comparison of low and high dosage regimens of SeroquelTM in the treatment of hospitalised patients with acute exacerbation of subchronic or chronic schizophrenia (1994) (9)
Elevated platelet phoshatidylinositol bisphosphate in medicated schizophrenics (1994) (9)
Continuous versus Intermittent Neuroleptic Therapy in Schizophrenia (1993) (8)
Cerebral Asymmetries in Unmedicated Schizophrenic Patients in EEG Spectra and Their Relation to Clinical and Autonomic Parameters (1984) (8)
[The scientific status of the theory that parents cause schizophrenia (author's transl)]. (1979) (8)
Consent and the Incompetent Patient (1988) (8)
Shortening hospital stay for psychiatric care. (1979) (7)
Schizophrenia, genetic retrenchment, and epidemiologic renaissance. The Sixth Biennial Winter Workshop on Schizophrenia, Badgastein, Austria, January 26-February 1, 1992. (1992) (7)
Testing the efficacy of new neuroleptic drugs. (1990) (7)
THE LAW AND MENTAL DISORDER (1979) (7)
Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function (2010) (7)
Name relearning in elderly patients with schizophrenia: Episodic and temporary, not semantic and permanent (2006) (7)
Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenia outpatients: Clinical and social outcome at 2 years (1990) (7)
Pragmatic evaluation of computer-aided self-help Pragmatic evaluation of computer-aided self-help for anxiety and depression for anxiety and depression (2003) (6)
Basolateral but not corticomedial amygdala shows neuroarchitectural changes in schizophrenia (2016) (6)
Stimulation of inositol phosphate production by propranolol in human neutrophils (1988) (6)
Regulation of the platelet polyphosphoinositide system by antipsychotic drugs: A specific neuroleptic action (1990) (5)
The effect of life events and medication in the aetiology of schizophrenic relapse (1993) (5)
Altered Brain Functional Organisation in Psychosis: Brain-Behaviour Relationships (1981) (5)
Blood polyamines in schizophrenia: A study of clozapine in drug resistant schizophrenic patients (1992) (5)
Facilities and services for patients who have chronic persisting severe disabilities resulting from mental illness (1993) (5)
SOCIAL STUDIES: Two, Four, Six, Eight When You Gonna Integrate? (1971) (5)
Services for the severe mentally ill — a planning blight (1992) (5)
Presence of a nitric oxide synthase inhibitor in schizophrenic subjects plasma (1995) (5)
The relationship of the area under the niacin flush dose-response curve and schizophrenia status (2000) (5)
Decreased glutamatergic binding sites in the left orbito-frontal cortex of chronic schizophrenics (1996) (4)
The platelets polyphosphoinositide system in schizophrenia: pathological and pharmacological implications (1989) (4)
A second open letter to the General Medical Council (1986) (4)
(Des-Tyr)-gamma-endorphin in the treatment of schizophrenia. (1981) (4)
The expression of the n-methyl-D-aspartate receptor subunit NR-I is decreased in schizophrenia (1995) (4)
Gender reassignment today. (1987) (3)
The effects of sensory deprivation on verbal communication. (1972) (3)
Brief intermittent neuroleptic prophylaxis for stable schizophrenic outpatients: two year outcome (1989) (3)
Ethical approaches to researching the mentally incapable patient (1995) (3)
Mismatch negativity potentials in relation to cognitive impairment in schizophrenia (2000) (3)
The subgenual cingulate gyrus exhibits lower rates of bifurcation in schizophrenia than in controls, bipolar disorder and depression (2012) (3)
Calcium mobilization in platelets from schizophrenic and healthy subjects. Regulation by lithium and neuroleptics (1992) (3)
Hypofrontality remits with schizophrenic recovery (1998) (2)
Schizophrenia: Evidence for Conceptualising It as a Brain Disease (2003) (2)
Stimulation of inositol phospholipid hydrolysis by propranolol in human neutrophils (1986) (2)
cortical pyramidal neurons in schizophrenia (1998) (2)
On the ability of schizophrenic patients to learn control of inter-hemispheric slow potential negativity (1998) (2)
287 – Changes in grey matter thickness in the frontal, temporal and occipital lobes in schizophrenia and depression (2008) (2)
Extra-sensory powers. A century of psychical research (1978) (2)
Oligodendrocyte abnormalities in mood and affective disorders in the anterior cingulate cortex and corpus callosum in the post-mortem brain (2008) (2)
Plasma polyamine oxidase in normal and schizophrenic subjects (1990) (2)
Flupenthixol and Fluphenazine Decanoate: A Comparative Review (1978) (2)
Regional specificity of changes in the expression of NMDA receptor and cholecystokinin MRNA in schizophrenia (1998) (2)
[Management of schizophrenic patients outside the hospital: results of research and basic principles]. (1976) (2)
Circulating l-arginine metabolites and platelet nitric oxide synthase in schizophrenics (1995) (1)
Anandamide induces chemiluminescence activating cyclooxygenase in human platelets and may have a role in schizophrenia (1998) (1)
106 A neuroanatomical study of glial cells in schizophrenia (1997) (1)
FRONTAL-LOBE HYPOFUNCTION IN SCHIZOPHRENIA (1984) (1)
United Kingdom: Neuroleptic Relapse Prevention (1991) (1)
Inositol phosphate formation in chemotactic peptide-activated neutrophils obtained from normal and schizophrenic subjects (1989) (1)
A positron emission tomography (PET) study of verbal fluency in well controlled schizophrenia and bipolar disorder (1998) (1)
Is the expression of cholecystokinin mRNA in schizophrenia region specific? (1996) (1)
Abstract 51. Cytomegalovirus and schizophrenia — a test of the virological hypothesis (1985) (1)
93-1 Plasma polyamine changes and possible effects on hypofunctional NMDA receptor found in schlzophrenic brain (1997) (1)
Depression in Schizophrenia: Crucial Issues and Further Evidence (1985) (1)
Extending neurotransmitter hypotheses of neuroleptic action and schizophrenia beyond cell-surface receptors. The phosphoinositide signalling system provides a link between receptors and intracellular calcium (1992) (1)
A prospective study of the interaction between life events and neuroleptic medication on the course of schizophrenic symptoms (1990) (1)
Working with clozapine — it can be done (1992) (1)
(Des‐tyr1)‐gamma‐endorphin (DTγE) in the treatment of depression: Double‐blind placebo‐controlled trial (1986) (1)
An automated position analysis of parvalbumin-immunoreactive cells in the cerebral cortex in control and schizophrenic pos-tmortem brain (1998) (1)
Examination of glial and neuronal changes in the nucleus basalis of Meynert in schizophrenia and recurrent depression (2011) (1)
Current Status of the Parental Causation Hypothesis in Schizophrenia (1978) (1)
Phagocytic activity of monocytes of panic disorder patients during benzodiazepine receptor activation (1991) (1)
Auditory Event-Related Potentials in Schizophrenic Patients1 (1983) (1)
The origin and treatment of schizophrenic disorders (1976) (1)
What price psychotherapy? (1984) (1)
The expression of the N-methyl-D-aspartate receptor subunit NR-1 messenger RNA in schizophrenia (1996) (1)
(Des-Tyr)gamma-endorphin for schizophrenia. A critical review. (1982) (1)
Consent and the Incompetent Patient: Ethics, Law, and Medicine : Proceedings of a Meeting Held at the Royal Society of Medicine, 9 December 1986 (1988) (1)
Willed movement in schizophrenia: A PET study (1996) (1)
Key points from the Report of the Royal College of Psychiatrists Working Party1 on Psychiatric Beds and Resources, 19862 (1987) (0)
The glutamate hypothesis of schizophrenia ∼ time to wake up the sleeping giant: A commentary on the paper (1996) (0)
Deficient memory encoding in the superior temporal gyrus of schizophrenic subjects (1998) (0)
The use and abuse of drugs in psychiatric out-patient therapy. (1973) (0)
27 Gamma band eeg oscillations in a man with bizarre somatic hallucinations (1998) (0)
Use of expectorants (1896) (0)
222 Correlation between NMDA receptor mRNA in temporal cortex and antemortem cognitive impairment in schizophrenia (1997) (0)
Cognitive disfunction in schizophrenia depends partially on short-term and delayed plasticity changes in schizophrenia, as reflected in mismatch negativity potentials (2001) (0)
99 A quantitative study of parvalbumin-immunoreactive interneurons in the cingulate gyrus of schizophrenic patients (1997) (0)
Analysis of gene expression in schizophrenia by in situ hybridization (1992) (0)
The South and North Camden schizophrenia surveys: The prevalence of schizophrenia by electoral ward and its relationship to social demographic factors (1990) (0)
Chromosome Anomalies, Mental Deficiency, and Schizophrenia (2017) (0)
290 – Changes in neuron structure within the nucleus basalis in schizophrenia (2008) (0)
Sean Spence (2011) (0)
Intellectual deficit masquerading as an amnesic syndrome in schizophrenia (2000) (0)
Neuroarchitectural changes are observed in the sub-nuclei of the amygdala in schizophrenia (2011) (0)
77 Dissociation of homogeneous from syndrome-related mismatch negativity lateral asymmetries in schizophrenia (1998) (0)
Elevated Plasma Endogenous Nitric Oxide Synthase Inhibitor May Indicate Abnormalities in Nmda Dependent Nitric Oxide Production in Schizophrenics (1996) (0)
Different pattern of cognitive dysfunction in schizophrenia and bipolar affective disorder (2003) (0)
Professional Responsibility & Consent To Treatment (1988) (0)
Planning for bed needs—Reply (1988) (0)
Precipitation of antipsychotic drugs in interaction with coffee or tea. (1979) (0)
Dendritic spine density in prefrontal cortex in schizophrenia (2000) (0)
Elevated platelet phosphatidylinositol bisphosphate in mediated schizophrenics. (1994) (0)
Consultant contract (1977) (0)
171 Increased cyclooxygenase/lipooxygenase acfivity in platelets from schizophrenic subjects indicates impaired arachidonic acid metabolism (1997) (0)
Book reviews (2001) (0)
Analysis of specific neuronal populations in schizophrenia by in situ hybridization: Functional and regional correlations (1995) (0)
The actor's brain: Exploring the cognitive neuroscience of free will (2012) (0)
MISCELLANEOUS: Requiem for Democracy? An Inquiry into the Limits of Behavioral Control. (1972) (0)
Dr Curson and Colleagues Reply (1985) (0)
The distribution of schizophrenia in inner London: Relationship to indices of social deprivation (1993) (0)
Histological examination of axonal changes in the fornix and corpus callosum in schizophrenia and depression (2011) (0)
Essential Aspects of the Research Problem in Schizophrenia (1988) (0)
Simultaneous assessment of cyclic AMP and cyclic GMP turnover by muscarinic and glutamate receptor agonists in rat brain cortical slices by high-performance thin-layer chromatography (1986) (0)
Gamma band eeg oscillations in a subject with somatic pseudo-hallucinations (1998) (0)
Ashley Robin: Formerly Consultant Psychiatrist Runwell Hospital, Essex Charing Cross Hospital (2002) (0)
Altered membrane fatty acid levels in schizophrenia (2000) (0)
Investigation of new candidate genes identified from extensive microarray analysis in schizophrenia: genotype correlations with expression (2011) (0)
Introduction (1994) (0)
Antidepressants and lorry driving (1991) (0)
Effects of bretazenil treatment on neutrophil phagocytosis of panic disorder subjects (1992) (0)
Increased platelet calcium mobilization and nitric oxide synthase activity—implications in schizophrenia (1996) (0)
Effect of ketamin on subcomponents of mismatch negativity: A case study (2000) (0)
Guns and me. (1994) (0)
Influenza Infection and Manic Psychosis (1974) (0)
S05.05 NMDA deficiency as a basis for the cognitive deterioration in schizophrenia (2000) (0)
THE ASSESSMENT OF ANTIPSYCHOTIC MEDICATION IN CLINICAL TRIALS (1993) (0)
The contribution of life events to schizophrenic relapse. An event history analysis (1992) (0)
Psychiatric ‘Experiments’—Moral and Ethical Issues (1979) (0)
Enlargement in Schizophrenia: A Ventrxular Preliminary Study (1987) (0)
Controlled clinical trials and medical ethics. (1979) (0)
Richard Green (2019) (0)
IQ impairment in schizophrenia: Evidence for a static encephalopathy? (2000) (0)
Commenting on Neuroimaging Commenting on Neuroimaging Further Comments on Jerusalem Further Comments on Jerusalem Syndrome Syndrome (0)
A cross-sectional study of MMSE scores in elderly schizophrenics (2000) (0)
Need for redefining the role of psychoanalysis. (1968) (0)
Persecution of academics in Turkey (1984) (0)
Introduction to the abstracts of the XIIIth Biennial Winter workshop on schizophrenia research (2006) (0)
Low dose maintenance medication for schizophrenia (1986) (0)
SAMARITANS: The Samaritans in the 70's. (1974) (0)
Future Strategies and Perspectives in Schizophrenia Research: Discussion (1990) (0)
sub-nuclei of the amygdala in schizophrenia (2011) (0)
Parietal hyperactivity in delusions of alien control (1996) (0)
Thrombin-induced formation of inositol phosphates by human neutrophils (1988) (0)
Violation of human rights against Chilean doctors (1981) (0)
Professor Hirsch replies (1988) (0)
MISCELLANEOUS: Compensation in Psychiatric Disability and Rehabilitation. (1972) (0)
syndromes, implying that the relevant psychological deficit is relatively subtle. The evidence that left temporal lobe epilepsy is associated with a psychosis characterised by delusions and hallucinations, but with relatively few symptoms of the psychomotor poverty or disorganisation syndromes (2006) (0)
Comprar Schizophrenia | Steven R Hirsch | 9780632063888 | Wiley (2008) (0)
BRIDGE MEN FOR PSYCHIATRY (1981) (0)
Mismatch negativity: Evidence for an NMDA-based disorder of brain plasticity in the temporal area which relates to cognitive disturbance in schizophrenia (2003) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Steven Richard Hirsch?

Steven Richard Hirsch is affiliated with the following schools:

Charing Cross and Westminster Medical School